Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study.
Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, Le Bouëdec MF, Gener G, Kurihara F, Bauvin O, Delauney J, Amsler E, Bara C, Pelletier F, Valois A, Castelain F, de Risi Pugliese T, Hamelin A, Barbaud A. Traineau H, et al. Among authors: gener g. J Allergy Clin Immunol Pract. 2024 Feb;12(2):460-468. doi: 10.1016/j.jaip.2023.10.021. Epub 2023 Oct 19. J Allergy Clin Immunol Pract. 2024. PMID: 37863314
Is a specific eyelid patch test series useful? Results of a French prospective study.
Assier H, Tetart F, Avenel-Audran M, Barbaud A, Ferrier-le Bouëdec MC, Giordano-Labadie F, Milpied B, Amsler E, Collet E, Girardin P, Soria A, Waton J, Truchetet F, Bourrain JL, Gener G, Bernier C, Raison-Peyron N; Dermato-Allergology Group of the French Society of Dermatology (DAG). Assier H, et al. Among authors: gener g. Contact Dermatitis. 2018 Sep;79(3):157-161. doi: 10.1111/cod.13040. Epub 2018 Jun 8. Contact Dermatitis. 2018. PMID: 29882592
[Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].
Ingen-Housz-Oro S, Assier H, Gener G, Milpied B, Soria A, Bernier C, Descamps V, Tetart F, Staumont-Sallé D, Valeyrie-Allanore L, Valois A, Sassolas B, Bensaid B, Lebrun-Vignes B, Barbaud A; Groupe FISARD de la SFD. Ingen-Housz-Oro S, et al. Among authors: gener g. Ann Dermatol Venereol. 2019 Apr;146(4):313-318. doi: 10.1016/j.annder.2019.01.010. Epub 2019 Mar 21. Ann Dermatol Venereol. 2019. PMID: 30904277 French. No abstract available.
Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions.
Bérot V, Gener G, Ingen-Housz-Oro S, Gaudin O, Paul M, Chosidow O, Wolkenstein P, Assier H. Bérot V, et al. Among authors: gener g. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):787-794. doi: 10.1111/jdv.15986. Epub 2019 Oct 28. J Eur Acad Dermatol Venereol. 2020. PMID: 31571276
Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience.
Roux C, Ben Said B, Milpied B, Bernier C, Staumont-Sallé D, Dezoteux F, Soria A, Barbaud A, Valeyrie-Allanore L, Tétart F, Bellon N, Lebrun-Vignes B, Gener G, Paul M, Ingen-Housz-Oro S, Assier H. Roux C, et al. Among authors: gener g. J Allergy Clin Immunol Pract. 2022 Dec;10(12):3252-3261.e2. doi: 10.1016/j.jaip.2022.07.008. Epub 2022 Jul 20. J Allergy Clin Immunol Pract. 2022. PMID: 35870724
24 results